Abstract-The influence of prenatal factors on the development of arterial hypertension has gained considerable interest in recent years. Prenatal dexamethasone exposure was found to induce hypertension and to alter nephron number and size in rodents and sheep. However, it is not clear whether these findings are applicable to nonhuman primates. Thus, we examined the effects of prenatal dexamethasone treatment on blood pressure (BP) and nephron number in marmoset monkeys. Fifty-two marmosets were allotted to 3 groups according to the gestational stage during which their mothers were exposed to oral 5-mg/kg dexamethasone for 7 days (gestation period: 20 weeks): (1) the early dexamethasone group at week 7; (2) the late dexamethasone group at week 13; and (3) the control group. BP was determined by telemetric (nϭ12) or cuff measurements (nϭ30), along with cystatin C, proteinuria, and body weight. All of the animals were euthanized at the age of 24 months, and glomerular number and volume were determined. Prenatal exposure to dexamethasone did not lead to a significant difference between the groups with regard to BP, kidney morphology and function, or body weight. BP correlated significantly with body weight, relative kidney weight, and mean glomerular volume and the body weight with the glomerular volume regardless of dexamethasone treatment. In conclusion, prenatal exposure to dexamethasone in marmosets does not, in contrast to other mammals studied, result in hypertension or changes in kidney morphology. Our data support the role of body weight as a predictor of elevated glomerular volume and BP development rather than prenatal dexamethasone exposure. Key Words: hypertension Ⅲ dexamethasone Ⅲ prenatal programming Ⅲ marmoset monkeys Ⅲ glomeruli number S ynthetic glucocorticoids such as dexamethasone (DEX) are often given to pregnant women with expected preterm birth to accelerate fetal pulmonary maturation and to prevent respiratory distress syndrome. However, prenatal administration of DEX may induce hypertension in combination with a lower number and increased volume of glomeruli in the later life of the offspring, as has been demonstrated for rodents and sheep. 1 The fetal origin of chronic diseases in adulthood was first proposed by Barker et al ("Barker hypothesis"). 2 The original epidemiological studies linked low birth weight with the risk of fatal ischemic heart disease 2 and with an increased risk for metabolic syndrome, including hypertension, dyslipidemia, and type 2 diabetes mellitus. 3 Therefore, the prevalence of metabolic syndrome, including hypertension, increased progressively, in both men and women, from those who had the highest to those who had the lowest birth weights. 3 Several subsequent experimental studies in rats and sheep inducing intrauterine growth restriction by maternal glucocorticoid exposure confirmed these epidemiological data. 1 A decreased number of glomeruli in the kidney were, therefore, proposed as one possible pathogenetic mechanism for the induction of hypertension. 3,4 The ...